SILEX SYSTEMS LIMITED (SLX)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

SLX - SILEX SYSTEMS LIMITED

FNArena Sector : Uranium

Year End: June

GICS Industry Group : Semiconductors & Semiconductor Equipment

Debt/EBITDA: -0.14

Index: ASX300 | ALL-ORDS

LAST PRICE	CHANGE +/-	CHANGE %	VOLUME
$4.74 20 Dec 2024	-0.260 OPEN $4.99	-5.20% HIGH $4.99	931,609 LOW $4.73

LAST PRICE

CHANGE +/-

CHANGE %

VOLUME

$4.74

20 Dec
2024

-0.260

OPEN

$4.99

-5.20%

HIGH

$4.99

931,609

LOW

$4.73

TARGET

$7.20

51.9% upside

OTHER COMPANIES IN THE SAME SECTOR
1AE . AEE . AGE . AKN . ASN . BKY . BMN . BOE . BSN . C29 . CXO . CXU . DEV . DYL . EL8 . EL8 . ERA . GLA . GTR . GUE . HAR . I88 . KOB . LAM . LOT . MEU . NXG . ORP . PDN . PEN . TOE . WCN .

FNARENA'S MARKET CONSENSUS FORECASTS

Title	FY22 Actual	FY23 Actual	FY24 Forecast	FY25 Forecast
EPS (cps)	xxx	- 8.1	- 1.3	xxx
DPS (cps)	xxx	0.0	0.0	xxx
EPS Growth	xxx	N/A	N/A	xxx
DPS Growth	xxx	N/A	N/A	xxx
PE Ratio	xxx	N/A	N/A	xxx
Dividend Yield	xxx	N/A	0.0%	xxx
Div Pay Ratio(%)	xxx	N/A	N/A	xxx

Dividend yield today if purchased 3 years ago: 0.00%

DIVIDEND YIELD CALCULATOR

Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

HISTORICAL DATA ARE ALL IN AUD

Copyright © 2024 FactSet UK Limited. All rights reserved

Title	2019	2020	2021	2022	2023	2024
EPS Basic	xxx	xxx	xxx	xxx	xxx	-9.6
DPS All	xxx	xxx	xxx	xxx	xxx	0.0
Sales/Revenue	xxx	xxx	xxx	xxx	xxx	6.9 M
Book Value Per Share	xxx	xxx	xxx	xxx	xxx	55.7
Net Operating Cash Flow	xxx	xxx	xxx	xxx	xxx	6.1 M
Net Profit Margin	xxx	xxx	xxx	xxx	xxx	-330.99 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title	2019	2020	2021	2022	2023	2024
Return on Capital Employed	xxx	xxx	xxx	xxx	xxx	-16.20 %
Return on Invested Capital	xxx	xxx	xxx	xxx	xxx	-16.12 %
Return on Assets	xxx	xxx	xxx	xxx	xxx	-15.48 %
Return on Equity	xxx	xxx	xxx	xxx	xxx	-16.20 %
Return on Total Capital	xxx	xxx	xxx	xxx	xxx	-6.62 %
Free Cash Flow ex dividends	xxx	xxx	xxx	xxx	xxx	5.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title	2019	2020	2021	2022	2023	2024
Short-Term Debt	xxx	xxx	xxx	xxx	xxx	0 M
Long Term Debt	xxx	xxx	xxx	xxx	xxx	1 M
Total Debt	xxx	xxx	xxx	xxx	xxx	1 M
Goodwill - Gross	xxx	xxx	xxx	xxx	xxx	-
Cash & Equivalents - Generic	xxx	xxx	xxx	xxx	xxx	117 M
Price To Book Value	xxx	xxx	xxx	xxx	xxx	9.57

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title	2019	2020	2021	2022	2023	2024
Capex	xxx	xxx	xxx	xxx	xxx	0.3 M
Capex % of Sales	xxx	xxx	xxx	xxx	xxx	4.16 %
Cost of Goods Sold	xxx	xxx	xxx	xxx	xxx	11 M
Selling, General & Admin. Exp & Other	xxx	xxx	xxx	xxx	xxx	5 M
Research & Development	xxx	xxx	xxx	xxx	xxx	4 M
Investments - Total	xxx	xxx	xxx	xxx	xxx	13 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
EXTRA COVERAGE

EXPERT VIEWS

Display All Commentary

Sentiment Indicator

1.0

No. Of Recommendations

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Shaw and Partners	30/08/2024	1	Buy, High Risk	$7.20	51.90%	Shaw and Partners simply notes Silex Systems has reported a FY24 net loss of -$23m. The company is currently running uranium enrichment trials at a Test Loop pilot facility in Wilmington, North Carolina. Success in the trials will be a potential catalyst for Cameco to exercise its option to acquire an additional 26% of the GLE joint venture, notes the broker, and should lead to US government funding. Target $7.20. Buy, High Risk. FORECAST Shaw and Partners forecasts a full year FY24 dividend of 0.00 cents and EPS of minus -1.30 cents. Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -13.10 cents.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Shaw and Partners

30/08/2024

Buy, High Risk

$7.20

51.90%

Shaw and Partners simply notes Silex Systems has reported a FY24 net loss of -$23m.

The company is currently running uranium enrichment trials at a Test Loop pilot facility in Wilmington, North Carolina.

Success in the trials will be a potential catalyst for Cameco to exercise its option to acquire an additional 26% of the GLE joint venture, notes the broker, and should lead to US government funding.

Target $7.20. Buy, High Risk.

FORECAST
Shaw and Partners forecasts a full year FY24 dividend of 0.00 cents and EPS of minus -1.30 cents.
Shaw and Partners forecasts a full year FY25 dividend of 0.00 cents and EPS of minus -13.10 cents.

Access Stockbroker Research History >

EXTRA COVERAGE

Display All Commentary

No. Of Recommendations

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER	DATE	RATING	RECOMMENDATION	TARGET PRICE	% TO REACH TARGET	COMMENTARY
Canaccord Genuity	05/09/2024	1	Buy	$6.21	31.01%	Silex Systems' operational update highlighted depleted UF6 has been successfully loaded into the Test Loop pilot facility in Wilmington ready for laser enrichment testing. If successful, completion will be one year earlier than originally planned and broadly in line with the accelerated schedule. Management will participate in the bidding process after the Department of Energy in the US allocated US$2.7bn in funding to boost the "domestic nuclear fuel supply chain" and launched an LEU request for proposals. The Speculative Buy rating and $6.21 target are maintained.

BROKER

DATE

RATING

RECOMMENDATION

TARGET PRICE

% TO REACH TARGET

COMMENTARY

Canaccord Genuity

05/09/2024

Buy

$6.21

31.01%

Silex Systems' operational update highlighted depleted UF6 has been successfully loaded into the Test Loop pilot facility in Wilmington ready for laser enrichment testing.

If successful, completion will be one year earlier than originally planned and broadly in line with the accelerated schedule.

Management will participate in the bidding process after the Department of Energy in the US allocated US$2.7bn in funding to boost the "domestic nuclear fuel supply chain" and launched an LEU request for proposals.

The Speculative Buy rating and $6.21 target are maintained.

Access Extra Coverage Research History >

SLX STOCK CHART

FNArena News on SLX

1	Rudi’s View: Banks, WiseTech, Redox & Integral Diagnostics Dec 19 2024 - Rudi's View

2	Next Week At A Glance -16-20 Dec 2024 Dec 13 2024 - Weekly Reports

3	Rudi’s View: Best Buys & Smaller Cap Favourites Dec 12 2024 - Rudi's View

4	Rudi’s View: In Santa We Trust (?) Dec 05 2024 - Rudi's View

5	Rudi’s View: Trump Beneficiaries & TechOne Nov 28 2024 - Rudi's View

Latest Uranium News

1	Uranium Week: Outlook For 2025 Dec 17 2024 - Weekly Reports

2	Uranium Week: Assad, Iran, Russia & The US Dec 10 2024 - Weekly Reports

3	Uranium Week: Gen Ai & Small Modular Reactors Dec 03 2024 - Weekly Reports

4	Uranium Unplugged: Nuclear Rebirth Meets Geo-Politics Nov 29 2024 - Commodities

5	Uranium Week: Supply Misses And Geo-Politics Nov 26 2024 - Weekly Reports

6	Uranium Week: From Russia With Love Nov 19 2024 - Weekly Reports

7	Uranium Week: Trump, Cameco & NextDC Nov 12 2024 - Weekly Reports

8	Uranium Week: Spot Price Fades Into Month’s End Nov 05 2024 - Weekly Reports

9	Paladin Energy’s Storm In A Teacup Oct 30 2024 - Small Caps

10	Uranium Week: US$94lb Spot In Reach? Oct 29 2024 - Weekly Reports

Dividend Yield Today On Last Actual Payout :	0.00
Estimated Dividend Growth (Average Of Past Three Years)	%
Amount Invested	$
Tell Me The Dividend After This Many Years

	Yield	Yield on investment
This Year
Year 1
Year 2
Year 3
Year 4
Year

Get 2 Weeks free trial

Sign Up

Member Login

SILEX SYSTEMS LIMITED (SLX)
Share Price Analysis and Chart